1. Home
  2. USEG vs SCLX Comparison

USEG vs SCLX Comparison

Compare USEG & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USEG
  • SCLX
  • Stock Information
  • Founded
  • USEG 1966
  • SCLX 2011
  • Country
  • USEG United States
  • SCLX United States
  • Employees
  • USEG N/A
  • SCLX N/A
  • Industry
  • USEG Oil & Gas Production
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • USEG Energy
  • SCLX Health Care
  • Exchange
  • USEG Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • USEG 40.5M
  • SCLX 35.7M
  • IPO Year
  • USEG N/A
  • SCLX N/A
  • Fundamental
  • Price
  • USEG $1.22
  • SCLX $17.74
  • Analyst Decision
  • USEG Strong Buy
  • SCLX Strong Buy
  • Analyst Count
  • USEG 1
  • SCLX 3
  • Target Price
  • USEG $3.50
  • SCLX $367.50
  • AVG Volume (30 Days)
  • USEG 322.9K
  • SCLX 316.5K
  • Earning Date
  • USEG 11-11-2025
  • SCLX 08-13-2025
  • Dividend Yield
  • USEG N/A
  • SCLX N/A
  • EPS Growth
  • USEG N/A
  • SCLX N/A
  • EPS
  • USEG N/A
  • SCLX N/A
  • Revenue
  • USEG $12,542,000.00
  • SCLX $44,236,000.00
  • Revenue This Year
  • USEG N/A
  • SCLX $89.26
  • Revenue Next Year
  • USEG $184.02
  • SCLX $203.95
  • P/E Ratio
  • USEG N/A
  • SCLX N/A
  • Revenue Growth
  • USEG N/A
  • SCLX N/A
  • 52 Week Low
  • USEG $0.98
  • SCLX $3.60
  • 52 Week High
  • USEG $6.40
  • SCLX $39.90
  • Technical
  • Relative Strength Index (RSI)
  • USEG 50.37
  • SCLX 41.69
  • Support Level
  • USEG $1.17
  • SCLX $14.80
  • Resistance Level
  • USEG $1.26
  • SCLX $19.41
  • Average True Range (ATR)
  • USEG 0.05
  • SCLX 3.30
  • MACD
  • USEG 0.00
  • SCLX -1.33
  • Stochastic Oscillator
  • USEG 28.13
  • SCLX 12.53

About USEG U.S. Energy Corp. (DE)

US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: